Hydrogen sulfide (H 2 S) has been traditionally known for its toxic effects on living organisms. The role of H 2 S in the homeostatic regulation of pancreatic insulin metabolism has been unclear. The present study is aimed at elucidating the effect of endogenously produced H 2 S on pancreatic insulin release and its role in diabetes development. Diabetes development in Zucker diabetic fatty (ZDF) rats was evaluated in comparison with Zucker fatty (ZF) and Zucker lean (ZL) rats. Pancreatic H 2 S production and insulin release were also assayed. It was found that H 2 S was generated in rat pancreas islets, catalyzed predominantly by cystathionine g-lyase (CSE). Pancreatic CSE expression and H 2 S production were greater in ZDF rats than in ZF or ZL rats. ZDF rats exhibited reduced serum insulin level, hyperglycemia, and insulin resistance. Inhibition of pancreatic H 2 S production in ZDF rats by intraperitoneal injection of DL-propargylglycine (PPG) for 4 weeks increased serum insulin level, lowered hyperglycemia, and reduced hemoglobin A1c level (Po0.05). Although in ZF rats it also reduced pancreatic H 2 S production and serum H 2 S level, PPG treatment did not alter serum insulin and glucose level. Finally, H 2 S significantly increased K ATP channel activity in freshly isolated rat pancreatic b-cells. It appears that insulin release is impaired in ZDF because of abnormally high pancreatic production of H 2 S. New therapeutic approach for diabetes management can be devised based on our observation by inhibiting endogenous H 2 S production from pancreas.
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This process occurs in different organs and tissues, such as neuronal, vascular, and intestinal tissues. 2 Physiological concentrations of circulating H 2 S have been reported in the range of 45-300 mM.
1 At this physiological range, exogenous H 2 S has been shown to relax different vascular tissues, including isolated rat aortae and perfused mesenteric artery bed. [3] [4] [5] Altered cell proliferation or apoptosis induced by H 2 S has also been widely reported. [6] [7] [8] [9] [10] Endogenous production and physiological function of H 2 S in pancreas have been studied with identification of both CBS and CSE in rat pancreatic tissues or cloned rat pancreatic b-cell line. 11, 12 In recent years, pathophysiological implications of the CSE/H 2 S system in diabetes have been reported. 12 CSE mRNA expression and H 2 S formation in rat pancreas was significantly increased after diabetes induction by streptozotocin injection. 12 CBS expression was reported in pancreatic acinar cells. 13 Yusuf et al 12 also detected the expression of CBS mRNA in mouse pancreas but whether this expression was located to pancreatic islets or other parts of the pancreas was not clear. The same research team later examined the expression of CBS in HIT-T15 cells, an insulinoma pancreatic b-cell line derived from Syrian hamster, 14 and no CBS protein was shown in these cells. In contrast, Kaneko et al 15 reported the expression of CBS protein in mouse pancreatic islets and a mouse b-cell line MIN6. We have shown that CSE is the major H 2 S-generating enzyme in pancreatic islet, demonstrated by significant CSE protein expression, 11 and by our published data that PPG abolished the most H 2 S production from cultured INS-1E cells.
Among demonstrated cellular and molecular mechanisms for physiological effects of H 2 S are the activation of K ATP channels by H 2 S. In vascular smooth muscle cells, exogenous and endogenous H 2 S activated K ATP channels at whole-cell and single channel levels. 16, 17 It is reasoned that H 2 S would also affect other excitable cells that have functional K ATP channels. Pancreatic b-cells are among these cells and our earlier study in fact demonstrated the activation of K ATP channels in an insulin-secreting cell line, INS-1E, by H 2 S. 11 The K ATP channel-dependent effect of H 2 S on insulin release has also been shown in another insulin-secreting cell line, HIT-T15. 14 Insulin release from pancreatic islets is a critical event in homeostatic control of glucose metabolism and in pathogenic process of insulin resistance development, including diabetes. As opening of K ATP channels leads to membrane hyperpolarization, insulin release from pancreatic islets would be inhibited because of reduced Ca 2 þ influx. Given that altered insulin release is critical for the development of diabetes and this process is likely to be modulated by H 2 S, it became imperative to gain better understanding on the role of H 2 S metabolism in the pathogenesis of diabetes and the underlying mechanisms. The present study focused on the altered endogenous pancreatic H 2 S production in Zucker diabetic fatty rats, a genetic animal model of type 2 diabetes mellitus. We also attempted to correlate this altered H 2 S production with insulin release from pancreatic islets and with the development of diabetes. Whether lowering endogenous pancreatic H 2 S levels of diabetic animals could reverse diabetes development was further investigated. Our results suggest that insulin release is impaired in diabetic animals and that inhibition of abnormally increased endogenous pancreatic H 2 S production in diabetes might represent a novel avenue for diabetes treatment.
MATERIALS AND METHODS Animal Model of Diabetes and Isolation of Pancreatic Islet and b-Cells
Male Zucker diabetic fatty (ZDF) rats, Zucker fatty (ZF) rats, and Zucker lean (ZL) rats (6-to 18-week-old) were received from Charles River Laboratories Inc. (Wilmington, MA). These animals were housed at 211C with 12-h light/dark cycles. After anesthetization of rats by intraperitoneal injection of sodium pentobarbital (50 mg/kg body weight), pancreatic islets were digested with collagenase and hand picked under microscope. The isolated islets (800-1000) were then dispersed into single cells by a brief (3-4 min) incubation in Ca 2 þ -free medium consisting of (in mM) 120 NaCl, 5 KCl, 2 MgSO 4 , 4 glucose, 1 EGTA, 25 Hepes-NaOH (pH 7.4), and 1% (w/v) bovine serum albumin (BSA). These cells were later used either for the patch-clamp recording or H 2 S production assay. The protocol for animal experiment was approved by the University of Saskatchewan Committee on Animal Care and Supply.
Measurements of Pancreatic islet H 2 S Production and Insulin Level
The measurement of H 2 S production rate in isolated pancreatic islets followed the established protocol in our laboratory. [3] [4] [5] 16 The isolated islets were collected by centrifuging at 1000 r.p.m. for 3 min and then homogenized in 50 mM ice-cold potassium phosphate buffer (pH 6.8). Homogenate (10%, w/v) was added to the reaction mixture containing (mM): 100 potassium phosphate buffer (pH 7.4), 10 L-cysteine, and 2 pyridoxal 5 0 -phosphate. Cryovial test tubes (2 ml) were used as the center wells, each containing 0.5 ml 1% zinc acetate as trapping solution and a filter paper 2 Â 2.5 cm 2 to increase air: liquid-contacting surface. Reaction was performed in a 25 ml Erlenmeyer flask (Pyrex, USA). The flasks containing the reaction mixture and center wells were flushed with N 2 before being sealed with a double layer of Parafilm. Reaction was initiated by transferring the flasks from ice to a 371C shaking water bath. After incubating at 371C for 90 min, 0.5 ml of 50% trichloroacetic acid was added to stop the reaction. The flasks were sealed again and incubated at 371C for another 60 min to ensure a complete trapping of H 2 S released from the mixture. Contents of the center wells were then transferred to test tubes, each containing 3.5 ml of water. Subsequently, 0.5 ml of 20 mM N,N-dimethyl-p-phenylenediamine sulfate in 7.2 N HCl was added immediately followed by addition of 0.5 ml 30 mM FeCl 3 in 1.2 N HCl. Absorbance of the resulting solution at 670 nm was measured 20 min later with a spectrophotometer. H 2 S content was calculated against the calibration curve of standard H 2 S solutions. Serum H 2 S levels were measured on duplicated samples with a sulfide electrode (Lazar Research Laboratories, Los Angeles, CA) 18 on an Accumet Model 10 pH meter (Fisher Scientific, Pittsburgh, PA).
For insulin release determination, the isolated pancreatic islets were washed and preincubated in glucose-free KrebsRinger-bicarbonate medium (pH 7.4) containing (mM): 135 NaCl, 3.6 KCl, 5 NaHCO 3 , 0.5 NaH 2 PO 4 , 0.5 MgCl 2 , 1.5 CaCl 2 , 10 Hepes, and 0.1% BSA. After 60 min preincubation, islets were incubated at 371C in the presence of different glucose concentrations with or without PPG. At the end of 30-min incubation period, the incubation medium was collected and insulin content determined using the rat insulin ELISA kit (Mercodia AB, Sylveniusgatan, Uppsala, Sweden).
Samples of blood were collected into EDTA-coated tubes from overnight fasted rats. The blood samples were then centrifuged (2500 g) at 41C for 15 min and derived serum stored at À201C. Insulin levels in serum were determined also with a rat-specific Insulin ELISA kit (Mercodia AB). [19] [20] [21] Blood hemoglobin A1c (HbA1c) level was measured by the Biochemistry Laboratory of Royal Hospital of the University of Saskatchewan.
Real-Time Quantitative PCR Real-time PCR was performed on an iCycler iQ real-time PCR detection system using SYBR Green PCR Master Mix 0 -AGGACGGTGGGGATGAAG-3 0 (antisense, position 1063-1080). These primers produced a product of 501 bp. The primers of b-actin (Ambion) produced a product of 295 bp. A standard curve was constructed with a series of dilutions of total RNA (Austin, TX, USA) transcribed to cDNA using the protocol outlined above to confirm the same amplifying efficiency in the PCR. A standard melting curve analysis was performed using a thermal cycling profile that began at 951C for 1 min, decreased to 551C for 1 min, and then ramped to 951C in one-degree increments to confirm the absence of primer dimers. Product size was determined by running PCR products on a 1.8% agarose gel. Relative mRNA quantification was calculated by using the arithmetic formula '2 ÀDDC T ', where DC T is the difference between the threshold cycle of a given target cDNA and an endogenous reference cDNA. 9, 22, 23 Thus, this value yields the amount of the target normalized to the endogenous reference of b-actin.
Western Immunoblotting
Isolated rat pancreatic islets were homogenized using a polytron homogenizer. The supernatants containing crude cellular proteins were resolved on a 10% SDS-PAGE gel, and transferred onto the PVDC nitrocellulose membrane. 24 The membrane was blocked with 3% nonfat dry milk solution in PBS at room temperature for 2 h and rinsed three times with PBS before incubating firstly with primary antibody (1:500 for CSE antibody, 1:5000 for b-actin antibody) and then with the HRP-conjugated secondary antibody (1:5000). The immunoreactions were visualized by ECL and exposed to X-ray film (Kodak Scientific Imaging film, X-omat Blue XB-1).
To prepare the anti-CSE polyclonal antibody, synthesized, and conjugated targeted peptide VGLEDEQDLLEDLD (Genbank accession no. AY083352, 377-392) were used to immunize male New Zealand rabbits. After the titer of anti-CSE antisera reached 1:4000, they were subjected to purification by protein G affinity. Purified antibody was eluted with 0.1 M glycine buffer (pH 2.5), and stored at À801C for later use.
Glucose Tolerance Test and Insulin Tolerance Test
Glucose tolerance test (GTT) was conducted by injecting the rats, after 12-h fast, with 1.5 g dextrose per kg body weight in a 50% dextrose solution intraperitoneally. Blood samples were collected from tails at different times after dextrose injection. Glucose levels were monitored using blood glucose strips (Onetouch, LifeScan). For insulin tolerance test (ITT), the rats were fasted for 12 h and then received insulin injection (1 U/kg, i.p.). Blood glucose levels were assessed before and 15, 30, 45, 60, and 90 min into the ITTs. 25 Electrophysiological Recording of K ATP Channel Currents Suspensions of dispersed cells from pancreatic islets were centrifuged at 100 r.p.m. for 3 min and the collected cells were then resuspended in Hepes-buffered RPMI 1640 (Sigma, USA). The freshly isolated single cells were tested for their K ATP channel response to high glucose to confirm their identity as pancreatic b-cells. Only those cells of which K ATP channel activity was significantly decreased by high glucose (16 mM) and inhibited by K ATP channel blocker, gliclazide, were used in this study. 11 The cells in the recording chamber were superfused continuously with the bath solution at a rate of about 2 ml/min. A complete solution change in the recording chamber was accomplished within 30 s. All electrophysiological experiments were conducted at room temperature (20-221C) .
The whole-cell K ATP channel currents of single b-cells were recorded at a membrane potential of À60 mV. 17 Recording electrodes were pulled from soft microhematocrit capillary tubes (Fisher Scientific, Nepean, ON) with tip resistance of 2-4 MO when filled with the pipette solution. Currents were recorded with an Axopatch 200-B amplifier (Axon Instruments), controlled by a Digidata 1200 interface and pCLAMP software (version 6.0, Axon Instruments). Membrane currents were filtered at 1 kHz with a four-pole Bessel filter, digitized, and stored. At the beginning of each experiment, junction potential between pipette and bath solutions was electronically adjusted to zero. The bath solution for recording the whole-cell K ATP currents contained (in mM) NaCl 140, KCl 5.4, MgCl 2 1.2, HEPES 10, EGTA 1, glucose 5 (pH adjusted to 7.4 with NaOH). The pipette solution was composed of (in mM) KCl 140, MgCl 2 1, EGTA 10, HEPES 10, glucose 5, Na 2 ATP 0.3, MgGDP 0.5, and PPG 5 (pH adjusted to 7.2 with KOH). The K þ concentration of bath solutions was increased to 140 mM, after stable K ATP currents were recorded, by the removal of equal-molar NaCl.
Chemicals and Statistical Analysis
The H 2 S-saturated solution (0.09 M) was freshly made by bubbling pure H 2 S gas (Praxair; Mississauga, Canada) into Krebs' solution at 301C for 40 min as described previously. 5 H 2 S stock solution was diluted to different concentrations into cell culture medium, and the pH of medium was adjusted to 7.4. Data are expressed as mean ± s.e.m. Multiple comparisons were made with one-way ANOVA followed by a post hoc analysis (Tukey's test). Statistical significance was set at Po0.05.
RESULTS

Pancreatic Production of H 2 S
To elucidate enzymatic basis of pancreatic H 2 S production, we firstly examined transcriptional expression of CSE and CBS. Although both CSE and CBS transcripts were detected in pancreatic islet tissues, quantitative comparison using realtime RT-PCR revealed that expression level of CSE was significantly higher than that of CBS in 16-week-old diabetic ZDF or nondiabetic ZF rats ( Figure 1a) . As CBS mRNA was extremely weak in pancreatic islet tissues, the following western blot studies were focused on CSE proteins. The expression level of CSE proteins was significantly higher in pancreatic islets of 16-week ZDF rats than that of age-matched ZL and ZF rats (Figure 1b) . Production rate of endogenous H 2 S in pancreatic islet tissues was also significantly greater in ZDF than that of ZF and ZL rats (Figure 1c) . Neither CSE protein expression nor H 2 S production in pancreatic islets was different between nondiabetic ZL and ZF rats.
Diabetic Status of ZDF Rats
At age of 8 weeks, ZDF rats did not develop diabetes and their overnight fasted blood glycated haemoglobin (HbA1c) level was 3.68 ± 0.31% (n ¼ 5, P40.05 vs ZL rats). However, even at this prediabetic stage, increased expression of CSE protein in pancreatic islets from ZDF rats already became significant (Figure 2 ).
Blood glucose level of both ZL and ZF rats at different ages remained within normal range (Figure 3a and b) . Hyperglycemia gradually developed, however, in ZDF rats as they aged and reached plateau at 12-13 weeks (Figure 3c ). HbA1c level was significantly higher in 16-week ZDF (6.34 ± 0.27%, n ¼ 6) than in age-matched ZL (4.63 ± 0.10%, n ¼ 4) and ZF rats (5.4 ± 0.4%, n ¼ 5; Po0.05).
Correlation of H 2 S Production and Glucose Metabolism in Diabetes
To reveal the role of endogenously produced H 2 S in the development of diabetes, 12-week ZDF or ZF rats were treated with PPG (33.9 mg/kg/day, i.p.) for 4 weeks or with AOA (30-100 mg/kg per day, i.p.) for 6 weeks to specifically inhibit CSE activity or CBS activity, respectively. Control groups of ZDF and ZF rats were injected with equal volumes H 2 S and insulin release in diabetes L Wu et al of PBS, the solvent for PPG or AOA, for the same period. For each injection, the rats received about 0.45-0.65 ml drug solution or PBS dependent on their body weights. At the end of 4-or 6-week injection period, the animals (aged 16-18 weeks) were terminated and assayed. PPG treatment drastically reduced H 2 S production rate to near zero in pancreatic islets from both ZDF and ZF rats (Figure 1c) . Although it had no effect on blood glucose level of ZF rats aged 8-16 weeks (Figure 3b) , the 4-week PPG treatment brought hyperglycemia of ZDF rats down to near normal level (Figure 3c ). HbA1c level of ZDF rats (6.3±0.3%, n ¼ 5) was significantly lowered by PPG treatment to 5.3±0.04% (n ¼ 3; Po0.05), which was still higher than that of ZL rats (Po0.05) but not significantly different from that of ZF rats (n ¼ 5).
Although CBS expression was minimal in pancreatic islet tissues (Figure 1a) , the role of CBS in the development of hyperglycemia of ZDF was nevertheless investigated. Treatment with AOA, a specific blocker of CBS, for 6 weeks did not significantly change hyperglycemic status of ZDF rats. HbA1c level of ZDF rats remained as high as 7.37±0.02 or 7.14 ± 0.03% after AOA treatments at 30 mg/kg per day (n ¼ 4) or 100 mg/kg per day (n ¼ 4), respectively, whereas it was 6.3 ± 0.3% in the age-matched and untreated ZDF rats (n ¼ 5; P40.05).
Reduced hyperglycemia and HbA1c levels in PPG-treated ZDF could result from improved insulin release, which would facilitate insulin-sensitive glucose metabolism. After glucose injection, blood glucose levels of nondiabetic control ZL or ZF rats initially arose but then quickly fell to the preinjection levels within 2 h (Figure 4a) . ZDF rats have a significant deficiency in glucose clearance. Elevation of blood glucose level of ZDF rats after glucose injection followed a similar time course as nondiabetic rats. However, the blood glucose level of ZDF rats remained elevated throughout the entire study period. In PPG-treated ZDF rats, elevated blood glucose level significantly declined during the 2 h post-glucose injection period, albeit not completely back to the preinjection level (Figure 4a ). There was no significant difference in blood glucose levels during GTT between control ZL rats and PPG-treated ZL rats (Figure 4a ).
During GTT, the increase in serum insulin level of ZDF rats was delayed with much lower amplitude as compared with that of ZL rats (Figure 4b ). PPG treatment elevated the basal level of serum insulin of ZDF rats. Both the rate of increase and the peak amplitude of serum insulin level of PPG-treated ZDF rats were significantly increased in comparison with that of untreated ZDF rats (Figure 4b) . Moreover, PPG treatment had no significant effect on serum insulin level of ZL rats (Figure 4b ). Once reaching their peaks, serum insulin levels of all groups of rats returned to their respective basal levels within 1 h.
Alterations in Serum Insulin Level
Serum insulin levels in all groups of 8-week rats were significantly lower than those of 16-week-old rats. Prediabetic 8-week ZDF rats had a serum insulin level of 1.34 ± 0.08 ng/ml (n ¼ 5), being significantly higher than that of age-matched ZL (0.78±0.01 ng/ml, n ¼ 3) and ZF rats (0.96±0.20 ng/ml, n ¼ 5; Po0.05). Serum insulin level was significantly lower in 16-week ZDF rats than age-matched nondiabetic ZL and ZF rats (Po0.01), although it was significantly higher in ZF than in ZL rats (Po0.01; Figure 5a ). Correlated with low serum insulin level was the elevated serum H 2 S level in ZDF rats. There was no significant difference in serum H 2 S level between ZF and ZL rats (P40.05), but a significantly higher serum H 2 S level was detected in ZDF rats than in ZF and ZL rats (Po0.05; Figure 5b ). PPG treatment increased serum insulin of ZDF rats to a level comparable to that of ZL rats (P40.05), but had no effect on that of ZF or ZL rats (Figure 5a ).
Insulin Tolerance and Pancreatic Insulin Release
Although they had a significantly lower serum insulin level (Figure 5a ), ZDF rats still developed insulin resistance (Figure 6a ). PPG treatment did not improve the impaired insulin resistance in ZDF rats (Figure 6a) . With a glucose challenge at basal level (5 mM), insulin release was significantly greater from ZF islets than ZL and ZDF islets.
Although insulin release from ZF islets in response to a highglucose challenge (20 mM) was still greater than other groups, insulin release from ZDF islets was significantly lower than that from all other groups. PPG (5 mM) incubation of ZDF islets largely restored the suppressed insulin release (Figure 6b ).
Opening of Pancreatic K ATP Channels by H 2 S Albeit major efforts have been focused on altered insulin levels in diabetes, not much is known on the underlying mechanisms toward impaired pancreatic release of that hormone. In freshly isolated rat pancreatic b-cells, shifting K þ concentration of the bath solution from 5.4 to 140 mM significantly increase the inward K ATP channel currents (Figure 7a and b) . With a holding potential of À60 mM and in the absence of Ca 2 þ from the bath solution, neither voltage-dependent K þ channel nor calcium-activated K þ channels would have been activated. 26, 27 H 2 S at 100 mM significantly increased K ATP channel currents that were subsequently inhibited by gliclazide (1 mM), a classical K ATP channel blocker, 28, 29 in b-cells from both ZL (Figure 7a ) and ZDF rats (Figure 7b ). The amplitude of K ATP channel cur- 
DISCUSSION
Altered insulin metabolism and reduced insulin sensitivity are two trademarks of diabetes mellitus. Albeit with concentrated attention being paid to different circulating insulin levels in diabetes, not much so has been known about altered insulin release from pancreas in diabetes and the underlying mechanisms. Insulin release from pancreatic b-cells is tightly coupled to glucose metabolism. In addition to an amplifying pathway putatively involving mitochondrial production of glutamate, 29 an extracellular calcium entrydependent mechanism controlled by K ATP channels in b-cell membrane is a pivotal event in glucose-regulated insulin release cascade. In this event, increase in circulating glucose results in production of ATP from b-cell mitochondria. A high ATP/ADP ratio subsequently closes K ATP channels in pancreatic b-cells, leading to membrane depolarization. 28 Resultant opening of voltage-dependent calcium channels injects more calcium into cytosolic milieu. This eventually leads to exocytosis of insulin granules.
In addition to affecting ATP levels, H 2 S also regulates K ATP channel activities. Recently, we showed that in INS-1E cells exogenous H 2 S at 100 mM had no effect on the whole-cell K ATP currents. After concentration of H 2 S was elevated to 300 mM, the amplitude of K ATP current in INS-1E cells was increased.
11 PPG is a specific inhibitor of CSE. 3, 17 Interestingly, in the presence of PPG that inhibited endogenous H 2 S production or with high glucose to inhibit K ATP channel activities in INS-1E cells, exogenous H 2 S at concentrations equal to or lower than 100 mM significantly increased K ATP channel currents. These results suggest that the functions of K ATP channels in INS-1E cells are related to endogenous H 2 S metabolism. After knocking down CSE gene expression in INS-1E cells, endogenous H 2 S level was significantly lowered and the whole-cell K ATP channel current density was significantly reduced in INS-1E cells in comparison with wild-type native cells, 11 further demonstrating the stimulatory effect of endogenous H 2 S on K ATP channels. INS-1E cells are from a pancreatic insulinoma cell line. Further evidence has been provided that 100 mM H 2 S directly reduced insulin secretion from INS-1E cells. The aforementioned studies have not addressed the relationship between pancreatic H 2 S metabolism and insulin release and development of hyperglycemia in diabetes. If endogenous H 2 S level was elevated in pancreatic b-cells, insulin release would be reduced and hyperglycemia would occur. The first step in proving this hypothesis is to determine endogenous production of H 2 S in pancreatic islet and its molecular basis. In the present study, we detected significant pancreatic islet production of H 2 S. In comparison with the expression level of CSE, the expression level of CBS mRNA in rat pancreatic islets is extremely low (Figure 1a) . Therefore, it is concluded that pancreatic islet H 2 S production is predominantly regulated by CSE, rather than CBS.
Next, we tried to elucidate the correlation of pancreatic H 2 S production with diabetes development by using ZDF rats. These rats represent a genetic animal model of type 2 diabetes mellitus, characterized with hyperglycemia, and peripheral insulin resistance. Serum insulin level of ZDF rats is initially higher but significantly drops after 7-10 weeks [30] [31] [32] when hyperglycemia developed. In our study, lower serum insulin level of 16-week-ZDF rats was confirmed at 1.02 ng/ ml, which is consistent with previous reported levels in 14-to 17-week-old ZDF. 33, 34 Serum insulin level of 16-week-ZL rats (2.39 ng/ml) was significantly higher than that of ZDF, similar as reported previously in 12-to 16-week-ZL rats. [35] [36] [37] Serum insulin level of 16-week-ZF rats (6.30 ng/ml) was significantly higher than both ZDF and ZL rats.
38-40 The abnormally lower serum insulin level in ZDF rats is closely related to H 2 S metabolism. Both expression of CSE and H 2 S production rate in pancreatic islets were significantly higher in ZDF than in ZL or ZF rats (Figure 1b and c) . Serum H 2 S level of ZDF was also significantly higher than that of ZF or ZL rats (Figure 5b) . A greater pancreatic H 2 S production would underlie reduced insulin release from pancreatic b-cells of ZDF rats. Molecular basis for H 2 S-suppressed insulin release appears to be activation of K ATP channels by high level of endogenous H 2 S in pancreatic b cells. This notion has been previously demonstrated by our group on INS-1E cells, 11 and further confirmed in the present study on freshly isolated rat pancreatic b-cells. H 2 S at a physiologically relevant concentration increased the amplitude of whole-cell K ATP channel currents in these b-cells. It should be pointed out that the demonstration of K ATP activation by H 2 S in b-cells from Zucker rats does not exclude other potential pancreatic targets of H 2 S in insulin release process. Altered cellular redox status by H 2 S would be one example of these targets. Low levels of H 2 S (30-50 mM) decreased reactive oxygen species (ROS) in cultured vascular smooth muscle cells. 41 Moreover, high level of NaHS (a donor of H 2 S) at 0.5 mM has been shown to deplete glutathione in isolated hepatocytes and increase hepatocyte formation of ROS, leading to cytotoxicity. 42 Taking the same token, increased endogenous level of pancreatic H 2 S production in ZDF rats might increase ROS level and decrease b-cell mass. We have also previously demonstrated a proapoptotic effect of H 2 S on INS-1E cells. H 2 S increased ER stress of INS-1E cells and suppression of ER stress significantly decreased H 2 S-induced apoptosis. 43 To further draw a correlation among pancreatic H 2 S metabolism, insulin release, and development of hyperglycemia, ZDF rats were treated with PPG. The inhibition of CSE activity by PPG in ZDF rats directly led to negligible pancreatic H 2 S production, further confirming the role of CSE as the dominant H 2 S-generating enzyme in pancreatic islet tissues. Residual H 2 S content in serum after PPG treatment indicates that H 2 S production remains functional in other tissues where CBS is the major H 2 S-producing enzyme. Diabetes is featured with failure to appropriately handle excess sugar presented after acute glucose uptake. Our present study revealed that PPG treatment improved glucose tolerance of ZDF rats (Figure 4a ), which can be explained by improved insulin release in these rats (Figure 4b ), because of reduced pancreatic H 2 S production. PPG treatment significantly lowered hyperglycemia and high HbA1c level of ZDF rats to near normal levels. These antidiabetic effects of PPG can be attributed to suppression of the inhibitory effect of H 2 S on pancreatic insulin release. To this end, decreased insulin release by high endogenous level of H 2 S as happened in untreated ZDF rats and increased insulin release by low endogenous level of H 2 S as happened in PPG-treated ZDF rats have been demonstrated. One limitation of this study, however, is that PPG treatment was conducted only at one concentration. Whether at this concentration PPG produces nonspecific effect on insulin release independent of the inhibition of CSE cannot be concluded yet.
A critical role of endogenous H 2 S in pancreatic islets in regulation of insulin release is unmasked in the present study. Abnormally elevated CSE gene expression and increased H 2 S production might constitute one of pathogenic mechanisms for diabetes. In this context, a hypothetic model of 'sweetened rotten egg' for physiological regulation of pancreatic function is proposed. This model integrates the role of pancreas in regulation of 'sweet' glucose metabolism and inhibitory role of the 'rotten egg' gas H 2 S in insulin release. As abnormal insulin release is ubiquitous for many disorders of insulin resistance syndrome, including obesity and hypertension, a critical evaluation of the role of pancreas as a 'sweetened rotten egg' will shed light on understanding of pathogenesis and management of these disorders.
